acetyl-aspartyl-glutamyl-valyl-aspartal and Leukemia-Lymphoma--Adult-T-Cell

acetyl-aspartyl-glutamyl-valyl-aspartal has been researched along with Leukemia-Lymphoma--Adult-T-Cell* in 2 studies

Other Studies

2 other study(ies) available for acetyl-aspartyl-glutamyl-valyl-aspartal and Leukemia-Lymphoma--Adult-T-Cell

ArticleYear
The large subunit of replication factor C is a substrate for caspase-3 in vitro and is cleaved by a caspase-3-like protease during Fas-mediated apoptosis.
    The EMBO journal, 1997, Nov-03, Volume: 16, Issue:21

    Caspase-3 is an ICE-like protease activated during apoptosis induced by different stimuli. Poly(ADP-ribose) polymerase (PARP), the first characterized substrate of caspase-3, shares a region of homology with the large subunit of Replication Factor C (RF-C), a five-subunit complex that is part of the processive eukaryotic DNA polymerase holoenzymes. Caspase-3 cleaves PARP at a DEVD-G motif present in the 140 kDa subunit of RF-C (RFC140) and evolutionarily conserved. We show that cleavage of RFC140 during Fas-mediated apoptosis in Jurkat cells and lymphocytes results in generation of multiple fragments. Cleavage is inhibited by the caspase-3-like protease inhibitor Ac-DEVD-CHO but not the caspase-1/ICE-type protease inhibitor Ac-YVAD-CHO. In addition, recombinant caspase-3 cleaves RFC140 in vitro at least at three different sites in the C-terminal half of the protein. Using amino-terminal microsequencing of radioactive fragments, we identified three sites: DEVD723G, DLVD922S and IETD1117A. We did not detect cleavage of small subunits of RF-C of 36, 37, 38 and 40 kDa by recombinant caspase-3 or by apoptotic Jurkat cell lysates. Cleavage of RFC140 during apoptosis inactivates its function in DNA replication and generates truncated forms that further inhibit DNA replication. These results identify RFC140 as a critical target for caspase-3-like proteases and suggest that caspases could mediate cell cycle arrest.

    Topics: Apoptosis; Caspase 3; Caspases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; DNA Replication; DNA-Binding Proteins; fas Receptor; Homeodomain Proteins; Humans; Leukemia-Lymphoma, Adult T-Cell; Lymphocytes; Minor Histocompatibility Antigens; Neoplasm Proteins; Oligopeptides; Proto-Oncogene Proteins c-bcl-2; Recombinant Fusion Proteins; Replication Protein C; Repressor Proteins; Saccharomyces cerevisiae Proteins; Substrate Specificity; Tumor Cells, Cultured

1997
Intracellular IL-1beta is an inhibitor of Fas-mediated apoptosis.
    Journal of immunology (Baltimore, Md. : 1950), 1996, Nov-01, Volume: 157, Issue:9

    Fas-mediated apoptosis has been shown to be mediated by the IL-1beta converting enzyme (ICE) pathway. To determine the relationship between ICE and its substrate IL-1beta, we examined six human cell lines for susceptibility to Fas-mediated apoptosis and Fas induction of ICE-like activity. The human B lymphoblastoid cell line SKW6.4 and the human T lymphoma cell lines Jurkat, CEM-6, H-9, and MOLT4 were susceptible to Fas-mediated apoptosis, whereas the human promyelocytic leukemia cell line HL-60 was resistant to Fas-mediated apoptosis. ICE mRNA was highly expressed in SKW6.4, H-9, and HL-60 cells, and ICE-like activity increased during Fas-mediated apoptosis in SKW6.4 cells. In contrast, IL-1beta mRNA was highly expressed only in HL-60 cells. Acetyl-Tyr-Val-Ala-Asp-chloromethylketone, a tetrapeptidyl inhibitor of ICE, prevented Fas-mediated apoptosis strongly in SKW6.4 and H-9 cells but weakly or marginally in other cells. To examine whether intracellular IL-1beta is a proteolytic substrate or an endogenous competitive inhibitor against other substrates for Fas-ICE-mediated apoptosis in SKW6.4 cells, we established precursor IL-1beta transfectant clones using SKW6.4 cells. We demonstrated that stably transfected SKW6.4 cells expressing precursor IL-1beta, but not cells transfected with the empty vector, exhibited resistance to Fas-mediated apoptosis due to competitive inhibition of ICE-like activity, which was associated with increased cleavage of precursor IL-1beta to mature IL-1beta. These results suggest that Fas-mediated apoptosis is mediated by ICE cleavage of proteolytic substrates other than IL-1beta and that IL-1beta is an endogenous inhibitor of Fas-mediated apoptosis.

    Topics: Amino Acid Chloromethyl Ketones; Apoptosis; B-Lymphocytes; Burkitt Lymphoma; Caspase 1; Cysteine Endopeptidases; Enzyme Induction; fas Receptor; HeLa Cells; HL-60 Cells; Humans; Interleukin-1; Intracellular Fluid; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, Large B-Cell, Diffuse; Oligopeptides; Protease Inhibitors; Protein Precursors; Recombinant Fusion Proteins; Signal Transduction; T-Lymphocytes; Transfection; Tumor Cells, Cultured

1996